Literature DB >> 19853750

Prenatal retinoic acid up-regulates pulmonary gene expression of COUP-TFII, FOG2, and GATA4 in pulmonary hypoplasia.

Takashi Doi1, Kaoru Sugimoto, Prem Puri.   

Abstract

PURPOSE: Retinoids play an important role in lung development. Recently, prenatal treatment with retinoic acid (RA) has been reported to stimulate alveologenesis in hypoplastic lungs in the nitrofen model of congenital diaphragmatic hernia (CDH). Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) is a transcription factor in the steroid/thyroid hormone receptor superfamily, and targeted ablation of COUP-TFII causes CDH and associated lung hypoplasia in mice. Friend of GATA 2 (FOG2) is a zinc finger-containing protein that modulates the transcriptional activity of GATA proteins. GATA4 is a member of a family of DNA-binding proteins, which is found in the promoter regions of many genes. The COUP-TFII, FOG2, and GATA4 genes, regulated by the retinoid signaling pathway, are located on chromosomes 15q26, 8q23, and 8p23.1 respectively, regions reported to be deleted in individuals with CDH. The aim of this study was to examine the pulmonary gene expression of COUP-TFII, FOG2, and GATA4 in the nitrofen model of CDH.
MATERIALS AND METHODS: Pregnant rats were exposed to either olive oil or 100 mg nitrofen on day 9 of gestation (D9). 5 mg/kg of RA was given intraperitoneally on days D18, D19, and D20. The fetuses were recovered by caesarean section on D21, and the diaphragm was carefully examined for the presence of a hernia under a microscope. Left lungs were obtained from CDH fetuses and controls and divided into four groups: control (n = 9), control + RA (n = 9), CDH (n = 9), and CDH + RA (n = 9). The relative mRNA expression levels of COUP-TFII, FOG2, and GATA4 were analyzed in each lung by real-time reverse transcriptase-polymerase chain reaction from cDNA generated by mRNA from pulmonary total RNA.
RESULTS: The relative mRNA expression levels of COUP-TFII, FOG2, and GATA4 were significantly increased in CDH + RA lungs compared to control, control + RA, and CDH (P < .05).
CONCLUSIONS: Up-regulation of pulmonary gene expression of COUP-TFII, FOG2, and GATA4 after prenatal treatment with retinoic acid in the nitrofen model of CDH suggests that RA may have a therapeutic potential in modulating lung growth. Furthermore, these results support the concept that these proteins work together to regulate downstream target genes that play an important role in the development of lung.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853750     DOI: 10.1016/j.jpedsurg.2009.04.027

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Prenatal retinoic acid upregulates pulmonary gene expression of PI3K and AKT in nitrofen-induced pulmonary hypoplasia.

Authors:  Takashi Doi; Kaoru Sugimoto; Elke Ruttenstock; Jens Dingemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2010-10       Impact factor: 1.827

2.  Prenatal administration of retinoic acid upregulates connective tissue growth factor in the nitrofen CDH model.

Authors:  Elke Maria Ruttenstock; Takashi Doi; Jens Dingemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-06       Impact factor: 1.827

3.  Prenatal treatment with retinoic acid activates parathyroid hormone-related protein signaling in the nitrofen-induced hypoplastic lung.

Authors:  Takashi Doi; Kaoru Sugimoto; Elke Ruttenstock; Jens Dingemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-01       Impact factor: 1.827

4.  Downregulation of Midkine gene expression and its response to retinoic acid treatment in the nitrofen-induced hypoplastic lung.

Authors:  Takashi Doi; Mika Shintaku; Jens Dingemann; Elke Ruttenstock; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-02       Impact factor: 1.827

5.  Prenatal retinoic acid treatment upregulates late gestation lung protein 1 in the nitrofen-induced hypoplastic lung in late gestation.

Authors:  Elke Maria Ruttenstock; Takashi Doi; Jens Dingemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-02       Impact factor: 1.827

6.  De novo frameshift mutation in COUP-TFII (NR2F2) in human congenital diaphragmatic hernia.

Authors:  Frances A High; Pooja Bhayani; Jay M Wilson; Carol J Bult; Patricia K Donahoe; Mauro Longoni
Journal:  Am J Med Genet A       Date:  2016-07-01       Impact factor: 2.802

7.  Combined antenatal therapy with retinoic acid and tracheal occlusion in a rat model of congenital diaphragmatic hernia.

Authors:  Augusto Frederico Schmidt; Frances Lilian Lanhellas Gonçalves; Rebeca Lopes Figueira; Federico Scorletti; Jose Luis Peiró; Lourenço Sbragia
Journal:  Pediatr Surg Int       Date:  2016-03-18       Impact factor: 1.827

8.  Variants in GATA4 are a rare cause of familial and sporadic congenital diaphragmatic hernia.

Authors:  Lan Yu; Julia Wynn; Yee Him Cheung; Yufeng Shen; George B Mychaliska; Timothy M Crombleholme; Kenneth S Azarow; Foong Yen Lim; Dai H Chung; Douglas Potoka; Brad W Warner; Brian Bucher; Charles Stolar; Gudrun Aspelund; Marc S Arkovitz; Wendy K Chung
Journal:  Hum Genet       Date:  2012-11-09       Impact factor: 4.132

Review 9.  Congenital diaphragmatic hernia.

Authors:  Juan A Tovar
Journal:  Orphanet J Rare Dis       Date:  2012-01-03       Impact factor: 4.123

Review 10.  Transcriptional Factors Mediating Retinoic Acid Signals in the Control of Energy Metabolism.

Authors:  Rui Zhang; Yueqiao Wang; Rui Li; Guoxun Chen
Journal:  Int J Mol Sci       Date:  2015-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.